Mannkind to expand Afrezza production capacity

May 5, 2015

Biopharmaceutical company Mannkind is expanding its production capacity for Afrezza, its inhaled insulin product.

Biopharmaceutical company Mannkind is expanding its production capacity for Afrezza, its inhaled insulin product.

Chief financial officer Matt Pfeffer told Connecticut's Danbury News Times on April 27 that the company was planning to triple capacity at its local manufacturing facility in the hope that demand for Afrezza will continue to increase in the coming months.

Pfeffer said that since its launch in February the drug, the first inhalable and fast-acting insulin, has been welcomed by patients with diabetes.

"Like any launch, it's going slow as expected but there are a lot of positive reports out there," Pfeffer told the newspaper. "The difference people say the drug is making in their lives is very encouraging. Our hope is that as more people become aware of its benefits, word will continue to spread."

Mannkind's Danbury plant is currently operating one manufacturing line that can produce up to 120 million cartridges of Afrezza each year. Later this quarter production will be expanded to three manufacturing lines, tripling the capacity to about 360 million cartridges. The plant was designed to accommodate up to 12 manufacturing lines.

The company also announced on Monday that it was preparing to manufacture a 12-unit cartridge strength of Afrezza, complementing the existing 4-unit and 8-unit cartridges. The 12-unit cartridge was approved by the U.S. Food and Drug Administration on April 17, 2015 and is expected to become available in the second half of 2015.

MannKind has formed a partnership with Sanofi to develop and commercialize Afrezza.

Sponsored Recommendations

2024 Manufacturing Trends — Unpacking AI, Workforce, and Cybersecurity

The world of manufacturing is changing, and Generative AI is one of the many change agents. The 2024 State of Smart Manufacturing Report takes a deep dive into how Generative ...

State of Smart Manufacturing Report Series

The world of manufacturing is changing, and Generative AI is one of the many change agents. The 2024 State of Smart Manufacturing Report takes a deep dive into how Generative ...

Trying to Keep Pace with Supply Chain Disruption?

CPG manufacturers are struggling to keep up with supply chain disruptions. Learn how to build more resilient operations –and reduce demand shock.

Mitigating Cybersecurity Threats – Step-by-Step

Distributor Wesco adds services focused on identifying and solving OT network and security vulnerabilities in critical manufacturing.